Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.
Engitix Therapeutics seeks a hands-on Scientist for the Antibody Discovery team in London to design and run binding assays (ELISA, SPR) and support discovery campaigns across multiple modalities. You’ll interpret data, troubleshoot issues and liaise with CROs as needed.
The role requires MSc/PhD-level biology experience, strong ELISA/SPR skills, and a proactive mindset in a fast-paced biotech setting. Join a team advancing fibrosis and oncology therapeutics at Engitix.
Engitix Therapeutics is a pioneering biotech company dedicated to unlocking extracellular matrix biology to develop transformative therapeutics in fibrosis and oncology. We are seeking an accomplished Scientist to join our Antibody Discovery team and play a hands‑on role in the screening and characterisation of antibody candidates across multiple modalities.
You will work closely with the team to design, run and interpret binding assays (ELISA, SPR), support antibody discovery campaigns, and liaise with external CROs. We are looking for someone who is proactive, comfortable working across different protein formats, and excited by the pace and variety of a biotech setting.
What you’ll do
You bring solid hands‑on lab experience; whether through an MSc plus a few years in industry, or a PhD, and are keen to apply your scientific training in a fast‑paced, commercially‑driven environment. You are curious and comfortable thinking. You thrive on variety, pick up new techniques quickly, and enjoy the pace and ownership that comes with working in a biotech. Above all, you are a team player who communicates clearly and enjoys collaborating with colleagues across functions.
What you’ll need
Desirable
Engitix is a growing biotech company based in White City Place, West London. We are dedicated to developing better therapies for advanced fibrosis and solid tumours by leveraging our pioneering extracellular matrix (ECM) platform. Our platform allows the synthesis of realistic in vitro 3D models that serve as tools to transform our ability to identify new targets and biomarkers, determine mechanisms of action and more accurately predict the efficacy of therapeutic candidates.
Join us today in our mission to create a healthier future for patients with life‑threatening diseases such as fibrosis and cancer.